(E,2S,3R)-2-aminooctadec-4-ene-1,3-diol

CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)N)O

InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/b15-14+/t17-,18+/m0/s1

WWUZIQQURGPMPG-KRWOKUGFSA-N

sphingosine; D-erythro-Sphingosine; 123-78-4; 4-Sphingenine; D-Sphingosine; Sphing-4-enine; Sphingenine; 4-trans-Sphingenine; (4E)-Sphingenine; (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol; trans-D-erythro-2-Amino-4-octadecene-1,3-diol; D-erythro-Sphingosine (synthetic); trans-4-Sphingenine; dl-Erythro-sphingosine; Erythro-dl-sphingosine; Sphingoid; (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol; c18-erythro-sphingenine; (2S,3R)-Sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; 4-octadecene-1,3-diol, 2-amino-, (2S,3R,4E)-; C18-Sphingosine; D-erythro-C18-Sphingosine; (-)-D-erythro-Sphingosine; (-)-Sphingosine; (E)-2-Amino-4-octadecan-1,3-diol; CCRIS 6899; erythro-4-Sphingenine; (2S,3R)-2-aminooctadec-4-ene-1,3-diol; (2S,3R,E)-2-aminooctadec-4-ene-1,3-diol; 2S-Amino-4E-octadecene-1,3R-diol; NGZ37HRE42; 0Y6SVQ612Q; 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E)))-; CHEBI:16393; 4-Octadecene-1,3-diol, 2-amino-, (E)-dl-erythro-; 4-Octadecene-1,3-diol, 2-amino-, (R*,S*-(E))-; 4-Octadecene-1,3-diol, 2-amino-, (2R,3S,4E)-rel-; 2-Aminooctadec-4-ene-1,3-diol; (2S,3R)-2-Amino-4-octadecene-1,3-diol; MLS-0412588.0001; sphingosin; (4E)-sphing-4-enine; Erythrosphingosine; SMR000857107; erythro-C18-Sphingosine; C18H37NO2; 2733-29-1; CHEMBL67166; MFCD00036751; UNII-NGZ37HRE42; 4-Octadecene-1,3-diol, 2-amino-, [R-[R*,S*-(E)]]-; UNII-0Y6SVQ612Q; DErySphingosine; C18 sphingosine; D-erythrosphingosine; EINECS 204-651-3; Sphingosine d18:1; D-Erythro-spinghosine; (E)-D-erythro-4-octadecene-1,3-diol; D-Sphingosine, synthetic; Sphingosine, C18 chain; BiomolKI_000034; SPHINGOSINE [MI]; BiomolKI2_000042; bmse000850; (2S,3R,E)-2-Amino-4-octadecene-1,3-diol; Sphingosine with C18 chain; Lopac0_001049; SCHEMBL19398; BSPBio_001526; MLS001332469; MLS001332470; MLS002172450; d18:1 D-erythro-sphingosine; BMK1-D10; BML3-C09; GTPL2452; SCHEMBL1471985; BDBM83205; CHEBI:26743; cid_5280335; DTXSID90861763; 4-Octadecene-1,3-diol, 2-amino-, (R*,S*-(E))-(+)-; HMS1361M08; HMS1791M08; HMS1989M08; HMS2232M04; HMS3402M08; HMS3650M05; D-(+)-erytho-4-trans-Sphingenine; DL-ERYTHRO-SPHINGOSINE [MI]; EX-A1428; ZINC8195650; EI-155; HB0239; LMSP01010001; s2210; D-Sphingosine, >=98.0% (TLC); AKOS024458590; CCG-100638; DB03203; ERYTHRO-SPHINGOSINE, (+/-)-; IDI1_033996; NCGC00024697-02; NCGC00024697-03; NCGC00024697-04; NCGC00024697-05; NCGC00024697-06; NCGC00024697-07; AC-28329; AS-66175; HY-101047; CS-0020759; S0874; (E,2S,3R)-2-amino-4-octadecene-1,3-diol; (E,2S,3R)-2-azanyloctadec-4-ene-1,3-diol; C00319; F20671; Q46298; D-Sphingosine, from bovine brain, ~99% (TLC); A901185; SR-01000597656; (2S,3R)-(E)-2-amino-1,3-dihydroxy-4-octadecene; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-ene-1-ol; J-004983; Sphingosine (d18:1), D-erythro-sphingosine, powder; SR-01000597656-1; [R-[R*,S*-(E)]]-2-amino-4-Octadecene-1,3-diol; E66DE871-3B37-406A-891B-A804BDC7ABF9; 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- (9CI); 4-OCTADECENE-1,3-DIOL, 2-AMINO-, (E)-D-ERYTHRO-; 4-Octadecene-1,3-diol, 2-amino-, (E)-D-erythro- (8CI); 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E))); D-(+)-erythro-1,3-dihydroxy-2-amino-4-trans-octadecene; 4-OCTADECENE-1,3-DIOL, 2-AMINO-, (R*,S*-(E))-(+/-)-; Brain Sphingosine, D-erythro-Sphingosine (Brain, Porcine), powder; 89164-20-5; SQS